Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.7304
+0.0304 (4.34%)
At close: Jun 3, 2025, 4:00 PM
0.7483
+0.0179 (2.45%)
After-hours: Jun 3, 2025, 7:39 PM EDT

Immunic Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Net Income
-96.4-100.51-93.61-120.41-92.95-44.02
Upgrade
Depreciation & Amortization
0.150.130.110.080.090.04
Upgrade
Asset Writedown & Restructuring Costs
-4.8-32.97--
Upgrade
Stock-Based Compensation
7.828.537.17.935.952.75
Upgrade
Other Operating Activities
-0.441.720.524.7612.96-2.53
Upgrade
Change in Accounts Payable
-0.733.150.820.80.181
Upgrade
Change in Other Net Operating Assets
7.02-2.5814.238.73-9.46-3.37
Upgrade
Operating Cash Flow
-82.57-84.77-70.83-65.14-83.23-46.12
Upgrade
Capital Expenditures
-0.28-0.26-0.33-0.11-0.07-0.15
Upgrade
Investment in Securities
--9.8-9.63--
Upgrade
Investing Cash Flow
-0.28-0.269.46-9.74-0.07-0.15
Upgrade
Long-Term Debt Issued
-74.27----
Upgrade
Net Debt Issued (Repaid)
-74.27----
Upgrade
Issuance of Common Stock
0.080.271.0399.7745.84154.56
Upgrade
Other Financing Activities
-0.01-0.01--4.01-3-10.13
Upgrade
Financing Cash Flow
0.0874.541.0395.7642.84144.43
Upgrade
Foreign Exchange Rate Adjustments
-0.23-0.520.26-0.99-0.13-0.08
Upgrade
Net Cash Flow
-83.01-11.01-60.0719.88-40.5998.08
Upgrade
Free Cash Flow
-82.85-85.03-71.16-65.26-83.3-46.27
Upgrade
Free Cash Flow Per Share
-0.82-0.85-1.61-2.05-3.52-2.95
Upgrade
Levered Free Cash Flow
-47.95-53.29-39.98-36.03-49.48-30.37
Upgrade
Unlevered Free Cash Flow
-47.95-53.29-39.98-36.03-49.48-30.37
Upgrade
Change in Net Working Capital
-6.780.4-15.16-10.158.942.4
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q